The interaction between FTX and miR-342 was also validated in acute myeloid leukemia cells, resulting in the upregulation of another miRNA target, the ALG3 mannosyltransferase, thus contributing to drug resistance in acute myeloid leukemia. Here, FTX is linked to acute myeloid leukemia.